Cargando…

The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography

BACKGROUND: The aim of this study was to evaluate the diagnostic efficacy of (18)F-fluorocholine ((18)F-FCH) PET/CT for uremic hyperparathyroidism (uHPT) compared to (99m)Tc-sestaMIBI SPECT/CT and ultrasonography (US). METHODS: A total of 17 uHPT patients with stage 5 chronic kidney disease (CKD) we...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Yu, Li, Wenbo, Xia, Zhu, Lei, Chengming, Cao, Yiyi, Wang, Zhengjie, Pang, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933043/
https://www.ncbi.nlm.nih.gov/pubmed/31879808
http://dx.doi.org/10.1186/s13550-019-0583-9
_version_ 1783483133584211968
author Xue, Yu
Li, Wenbo
Xia, Zhu
Lei, Chengming
Cao, Yiyi
Wang, Zhengjie
Pang, Hua
author_facet Xue, Yu
Li, Wenbo
Xia, Zhu
Lei, Chengming
Cao, Yiyi
Wang, Zhengjie
Pang, Hua
author_sort Xue, Yu
collection PubMed
description BACKGROUND: The aim of this study was to evaluate the diagnostic efficacy of (18)F-fluorocholine ((18)F-FCH) PET/CT for uremic hyperparathyroidism (uHPT) compared to (99m)Tc-sestaMIBI SPECT/CT and ultrasonography (US). METHODS: A total of 17 uHPT patients with stage 5 chronic kidney disease (CKD) were prospectively enrolled. All patients underwent US, (99m)Tc-sestaMIBI SPECT/CT, and (18)F-FCH within 2 months and received surgical treatment. Visual and quantitative methods were used for image analyses. Intraoperative localization and postoperative histological results of the reference standard as well as the sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) of the three modalities were analyzed using Pearson’s χ(2) tests. In addition, the diagnostic efficacy of (18)F-FCH PET/CT for uHPT was evaluated. The relationships between PET parameters and laboratory parameters were assessed using the Spearman correlation coefficient. RESULTS: A total of 63 parathyroid hyperplasia lesions were resected in 17 uHPT patients, and 53 lesions were detected using (18)F-FCH PET/CT with no false-positive results. The sensitivity, specificity, accuracy, PPV, and NPV were 84.13%, 100%, 86.49%, 100%, and 52.38%, respectively. In comparison, the corresponding values for (99m)Tc-sestaMIBI SPECT/CT and US were 63.49%, 90.91%, 67.57%, 97.56%, and 30.30% and 61.90%, 81.82%, 64.86%, 95.12%, and 27.27%, respectively. The volume of hyper-functioning parathyroid glands was significantly different between lesions positive in (18)F-FCH PET/CT and negative in (18)F-FCH PET/CT (mean volume 1.36 ± 0.55 cm(3) vs. 0.83 ± 0.26 cm(3); P = 0.019). US misidentified intrathyroidal parathyroid hyperplasia as thyroid nodules in three patients, while (18)F-FCH PET correctly identified the anatomy. No significant associations were observed between PET parameters and laboratory parameters in uHPT. CONCLUSION: (18)F-FCH PET/CT was more sensitive and accurate for uHPT than (99m)Tc-sestaMIBI SPECT/CT and US, and had better preoperative diagnostic efficacy, particularly for lesions diagnosed as a thyroid nodule by US.
format Online
Article
Text
id pubmed-6933043
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-69330432020-01-09 The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography Xue, Yu Li, Wenbo Xia, Zhu Lei, Chengming Cao, Yiyi Wang, Zhengjie Pang, Hua EJNMMI Res Original Research BACKGROUND: The aim of this study was to evaluate the diagnostic efficacy of (18)F-fluorocholine ((18)F-FCH) PET/CT for uremic hyperparathyroidism (uHPT) compared to (99m)Tc-sestaMIBI SPECT/CT and ultrasonography (US). METHODS: A total of 17 uHPT patients with stage 5 chronic kidney disease (CKD) were prospectively enrolled. All patients underwent US, (99m)Tc-sestaMIBI SPECT/CT, and (18)F-FCH within 2 months and received surgical treatment. Visual and quantitative methods were used for image analyses. Intraoperative localization and postoperative histological results of the reference standard as well as the sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) of the three modalities were analyzed using Pearson’s χ(2) tests. In addition, the diagnostic efficacy of (18)F-FCH PET/CT for uHPT was evaluated. The relationships between PET parameters and laboratory parameters were assessed using the Spearman correlation coefficient. RESULTS: A total of 63 parathyroid hyperplasia lesions were resected in 17 uHPT patients, and 53 lesions were detected using (18)F-FCH PET/CT with no false-positive results. The sensitivity, specificity, accuracy, PPV, and NPV were 84.13%, 100%, 86.49%, 100%, and 52.38%, respectively. In comparison, the corresponding values for (99m)Tc-sestaMIBI SPECT/CT and US were 63.49%, 90.91%, 67.57%, 97.56%, and 30.30% and 61.90%, 81.82%, 64.86%, 95.12%, and 27.27%, respectively. The volume of hyper-functioning parathyroid glands was significantly different between lesions positive in (18)F-FCH PET/CT and negative in (18)F-FCH PET/CT (mean volume 1.36 ± 0.55 cm(3) vs. 0.83 ± 0.26 cm(3); P = 0.019). US misidentified intrathyroidal parathyroid hyperplasia as thyroid nodules in three patients, while (18)F-FCH PET correctly identified the anatomy. No significant associations were observed between PET parameters and laboratory parameters in uHPT. CONCLUSION: (18)F-FCH PET/CT was more sensitive and accurate for uHPT than (99m)Tc-sestaMIBI SPECT/CT and US, and had better preoperative diagnostic efficacy, particularly for lesions diagnosed as a thyroid nodule by US. Springer Berlin Heidelberg 2019-12-26 /pmc/articles/PMC6933043/ /pubmed/31879808 http://dx.doi.org/10.1186/s13550-019-0583-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research
Xue, Yu
Li, Wenbo
Xia, Zhu
Lei, Chengming
Cao, Yiyi
Wang, Zhengjie
Pang, Hua
The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography
title The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography
title_full The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography
title_fullStr The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography
title_full_unstemmed The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography
title_short The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography
title_sort role of (18)f-fch pet/ct in patients with uremic hyperparathyroidism compared with (99m)tc-sestamibi spect/ct and ultrasonography
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933043/
https://www.ncbi.nlm.nih.gov/pubmed/31879808
http://dx.doi.org/10.1186/s13550-019-0583-9
work_keys_str_mv AT xueyu theroleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography
AT liwenbo theroleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography
AT xiazhu theroleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography
AT leichengming theroleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography
AT caoyiyi theroleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography
AT wangzhengjie theroleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography
AT panghua theroleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography
AT xueyu roleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography
AT liwenbo roleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography
AT xiazhu roleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography
AT leichengming roleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography
AT caoyiyi roleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography
AT wangzhengjie roleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography
AT panghua roleof18ffchpetctinpatientswithuremichyperparathyroidismcomparedwith99mtcsestamibispectctandultrasonography